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Abstract 46 
Bioluminescence imaging (BLI) is an optical imaging method which can be translated 47 
from the cell culture dish in vitro to cell tracking in small animal models in vivo. In 48 
contrast to the more widely used fluorescence imaging which requires light excitation, in 49 
BLI the light is exclusively generated by the enzyme luciferase. The luciferase gene can 50 
be engineered to target and monitor almost every cell and biological process 51 
quantitatively in vitro and even from deep tissue in vivo. While initially used for tumor 52 
imaging, bioluminescence was recently optimized for mouse brain imaging of neural 53 
cells and monitoring of viability or differentiation of grafted stem cells. Here, we describe 54 
the use of bright color-shifted firefly luciferases (Fluc) based on the thermostable x5 Fluc 55 
that emit red and green for effective and quantitative unmixing of two human cell 56 
populations in vitro and after transplantation into the mouse brain in vivo. Spectral 57 
unmixing predicts the ratio of luciferases in vitro and a mixture of cells precisely for 58 
cortical grafts, however, with less accuracy for striatal grafts. This dual-color approach 59 
enables the simultaneous visualization and quantification of two cell populations on the 60 
whole brain scale with particular relevance for translational studies of neurological 61 
disorders providing information on stem cell survival and differentiation in one imaging 62 
session in vivo.  63 
 64 
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Introduction 92 
Firefly luciferases (Flucs) are very efficient molecular and biochemical tools to track 93 
cells, proteins, and to monitor gene expression in living organisms 1. While the first 94 
bioluminescence imaging (BLI) was limited to tumor applications 2, the firefly gene and 95 
the detection hardware were continuously optimized to monitor other cell types, such as 96 
stem cells and neurons, in deep tissue with higher or equal sensitivity and specificity 97 
compared to for example fluorescence imaging 3–8. BLI has some unique advantages 98 
such as the light is produced directly in the Fluc expressing cells without the need of an 99 
excitation source, promoting a very low background and high signal-to-noise ratios 100 
(SNR). The efficiency of in vivo light production enables the detection of a minimal 101 
number of 1,500 to 3,000 neural stem cells (NSCs) engrafted to the mouse brain, 102 
through the intact skull, connecting tissue, and skin 9,10. The survival rate of transplanted 103 
cells, which is an important factor to determine the outcome of translational stem cell 104 
studies, can be derived from the quantitative BLI signal, which requires adenosine 105 
triphosphate (ATP) for the luciferase enzyme reaction 11. Furthermore, the luciferase 106 
gene was engineered to monitor the stem cell fate, for example the differentiation of 107 
stem cells into early neurons in vivo 12. However, these measurements can be 108 
performed to-date only in separate, single color experiments. Multicolor BLI, the 109 
simultaneous imaging of two or more luciferases with distinct emission spectra, emerged 110 
first for in vitro assays and later for imaging bacteria or tumor cells in vivo 13–16. Spectral 111 
unmixing an algorithm that can distinguish the spectral signatures is applied to extract 112 
the signal from two luciferases emitting light at different wavelengths and to calculates 113 
the respective contribution of each reporter on every pixel of an image 16,17. 114 
The aim of this study was to probe spectral unmixing for bioluminescence neuroimaging 115 
with a focus on cell transplantation and to quantify the reliability of dual-color 116 
measurements. We describe experiments with a bright red-shifted 18,19 and a novel 117 
green-shifted point mutant of x5, a thermostable variant of wild type Fluc but with higher 118 
quantum yields 20,21. This dual-color pair was chosen based on a comparison to other 119 
commonly used red/green Fluc mutants which showed efficient spectral unmixing in a 120 
cell assay in vitro. Furthermore, we provide for the first time a quantitative in vivo 121 
discrimination and unmixing-based estimation of two human neural stem cell populations 122 
in the mouse brain. Such multiplexed bioluminescence approaches will be useful to 123 
monitor the interaction of multiple cell populations in vivo and facilitate quantitative dual-124 
color neuroimaging.  125 
 126 
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Results 139 
 140 
In vitro spectral unmixing 141 
Previously described variations of wildtype (WT) firefly luciferase (Fluc) containing 5 142 
mutations (F14R, L35Q, V182K, I232K, F465R)22 that reduce surface hydrophobicity 143 
and confer significant thermostability, were further mutated to red-shift (S284T) mutant 144 
x5red (x5r)18 and to produce a novel blue-shifted (V241I/G246A/F250S) mutant x5green 145 
(x5g) bioluminescence spectra. In vitro, this novel dual-color Fluc pair was tested 146 
against the bioluminescence spectra of WT Fluc (Promega, Madison, WI, USA), 147 
PpyRE9 Fluc mutant 23, click beetle luciferase CBG99 24, and Renilla luciferase hRluc 25 148 
were acquired with the IVIS Spectrum CT system equipped with 18 emission filter (20 149 
nm bandpass) at 37°C. Each luciferase was expressed by transfection of lentiviral 150 
vectors in the human tumor cell line HEK 293T. The bioluminescence signal was 151 
corrected for the co-expressed copGFP fluorescence measured separately with a plate 152 
reader. Here, copGFP levels reflect the transfection-based differences in luciferase 153 
expression due to a specific viral T2A linker in the bicistronic lentiviral plasmid providing 154 
equal expression levels of both transgenes. The normalized in vitro spectra [Fig. 1] 155 
show differences in peak photon emission as well as spectra shape. Notably, x5g 156 
produced in our setting the highest total photon flux (area under curve, AUC) compared 157 
to CBG99 and Luc2 (1.79- and 3.69-fold, respectively). For x5r, we found the AUC value 158 
to be 2.24-fold higher compared to PpyRE9 but only 0.45-times of the total photons from 159 
Luc2. The photon flux from cells expressing hRluc cannot be compared directly due to 160 
the different substrate (coelenterazine), however, the spectra clearly indicates the strong 161 
monophasic blue/green light emission. In contrast, emission spectra of firefly and click 162 
beetle luciferases follow a biphasic spline and in vitro/in vivo emission maxima of 163 
520/560 nm (x5g, CBG99), 560/620 nm (PpyRE9, x5r) and 560/600 nm (Luc2). The 164 
spectral separation is higher for x5g/x5r for all measured wavelengths compared to the 165 
other green/red couples CBG99/PpyRE9, x5g/Luc2, and CBG99/Luc2. The second-best 166 
separation is achieved by combining x5g and Luc2.   167 
As the next step, we performed spectral unmixing of HEK 293T cells transfected with 168 
x5g or x5r Fluc [Fig. 2(a)]. With the automated spectral unmixing algorithm provided by 169 
the IVIS software, the green and red emission spectra of x5g and x5r were extracted 170 
[Fig. 2(b)] and used for prediction of the x5g/x5r ratio in different mixtures [Fig. 2(c)]. 171 
The quantitative analysis of the unmixing data revealed high accuracy of predicted x5g 172 
ratios in relation to the actual number of plated x5g cells [(Fig. 2(d)]. A linear regression 173 
analysis showed that for both spectra, the unmixed photon counts are in linear 174 
relationship to the amount of Fluc cells for both reporters, x5g and x5r (R2=0.991 175 
p<0.001 and R2=0.994, p<0.001). For the predicting the correct x5g/r ratios, the 176 
algorithm results in a very low mean average deviation (MAD) of 0.02±0.02.  177 
 178 
The influence of light absorption and scattering on the x5g/r Fluc photon emission was 179 
determined with a tissue-like blood agar mix consisting of gelatine, intralipid, and 180 
hemoglobin [Fig. 3(a)]. Plated x5g and x5r cells were covered with different amounts of 181 
the blood agar mix before imaging in order to mimic cell grafts implanted at different 182 
tissue depth. With increasing blood agar volume, the number of detected photons 183 
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decreased for x5r and x5g with an exponential two-phase decay [Fig. 3(b)]. The photon 184 
flux of x5g compared to x5r remained on average 1.79-fold higher independent of blood 185 
agar volume. Thus, under these in vitro conditions, no change in the x5g/r emission ratio 186 
was detected and no additional correction factor for the Fluc-specific absorption was 187 
calculated. 188 
In vivo spectral unmixing 189 
We determined the efficiency and accuracy of x5g and x5r Fluc unmixing in vivo by BLI 190 
of transfected HEK 293T cells which were transplanted into nude mouse brains and 191 
imaged on the following day. In comparison to other luciferases, x5g and x5r spectra 192 
exhibit substantial differences [Fig. 4]. The normalized spectra of x5g reveals in 193 
comparison to the green-shifted click beetle luciferase CBG99 at 560 nm a 2.07-fold 194 
higher photon flux. Thus, the green shoulder of the x5g spectrum is much more 195 
prominent. The differences between the two red-shifted firefly luciferases PpyRE9 and 196 
x5r in terms of total photon flux and shape of the spectrum are much less distinct.  197 
 198 
In order to identify the influence of transplantation depth, we performed experiments with 199 
two separate groups: the cortical (-1.5 mm depth) as well as striatal (-3.0 mm depth) 200 
grafts. The experimental setting [Fig. 5(a, d)] included mice with x5r and x5g cells only 201 
as well as mice which received both cell types in in different mixtures. The two control 202 
mice were used to extract the in vivo x5r and x5g spectra from the cortex and striatum 203 
group in the auto unmixing mode, in which the software automatically detects x5r and 204 
x5g [Fig. 5(b, e)]. Notably, the total photon flux of x5g and x5r luciferase in the cortex is 205 
1.93-fold and 1.76-fold higher compared to the striatum. The emission maximum of x5r 206 
is in both conditions at 620 nm but reached in the striatum only 58.44% photon flux of 207 
the photon flux of cortical grafts. In case of x5g, the spectrum in the striatal group is 20 208 
nm shifted and the maximal photon emission only 41.98% of the cortex group. In the 209 
cortex group, automatic unmixing of the x5g ratio worked well with high accuracy for all 210 
expected x5g ratios (F(4,13)=217.455, p<0.001). A general comparison of expected to 211 
calculated x5g ratio resulted in a significant effect (F(4,17)=79.961, p<0.001), however, 212 
with stronger linear correlation compared to the striatum (R2=0.994/p<0.001 vs. 213 
R2=0.933/p=0.008) [Fig. 5(c, f)]. A post-hoc comparison showed that for example the 214 
unmixing result is not precise enough to separate significantly cell grafts with 50 and 215 
75% x5g cells, respectively (p=0.179). In order to further calculate the accuracy of 216 
unmixing, the linear regressions for cortical and striatal grafts were statistically 217 
compared to the implanted x5g ratios [Fig. 4(c, f)]. The difference between the slopes for 218 
cortical and striatal grafts were not significantly different (p=0.319 and p=0.450). In 219 
addition, a one sample t test was calculated to compare the unmixing results with the 220 
known x5g ratio and the mean absolute deviation (MAD) was calculated to forecast the 221 
error in an experiment. For cortical and striatal grafts all unmixing ratios were not 222 
statistically significant different except of 100% x5g, which might be influenced by the 223 
small variation and sample size. The MAD for cortical grafts was smaller (4.5) compared 224 
to striatal grafts (8.0), supporting the observation that unmixing results and the expected 225 
x5g ratios were found to be very reliable for the cortex and less reliable for the striatum 226 
(Table 1).  227 
We further processed the data assuming a scenario where the two control mice with x5g 228 
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and x5r cells for the auto unmixing mode are not present. The in vivo spectra and mean 229 
attenuation factors calculated from at 3 (cortex) or 4 (striatum) independent experiments 230 
were used to generate “library” spectra and to guide the unmixing algorithm [Fig. 5(b, 231 
e)]. In this case, the two control mice x5r and x5g would become obsolete. However, our 232 
calculations reveal less precise spectral unmixing for cortical and striatal grafts (Table 233 
1). In the cortex group, statistically significant differences in x5g ratios were not 234 
predicted for 25 vs. 50 vs. 75% x5g cells in the mix. Most obvious is the strong under-235 
representation of x5g in the mix especially for the striatal grafts which leads to false 236 
unmixing results, e.g. for 50% x5g in the striatum 23.0±4.1%, which is statistically 237 
significant different from the implanted 50% x5g cells. Similarly, the linear relationship for 238 
the increasing ratio of x5g cells in the mix holds true but with inferior correlation 239 
compared to the automated unmixing (cortex: R2=0.939/p=0.007, striatum: 240 
R2=0.856/p=0.024).  241 
 242 
Table 1: Summary of in vivo unmixing validation.  243 
 
x5g% Auto unmixing and pairwise comparison 
One 
sample t 
test 
MAD1 Library unmixing
2
 and 
pairwise comparison MAD
2
 
One 
sample t 
test 
C
o
r
t
e
x 
0 1.7±2.3 
 p=0.239 1.7 0.9±1.0  0.9 p=0.120  
  ] p=0.035*    ] p=0.032*  
 
25 21.5±9.9  p=0.607 8.8 20.9±9.3  8.3 p=0.521  
  ] p=0.009**    ] p=0.189   
50 50.7±7.0  p=0.922 5.5 46.0±7.0      4.1 p=0.270 
  ] p=0.016*    ] p=0.100   
75 65.0±4.1  p=0.078 7.3 54.1±8.2  20.9 p=0.049* 
  ] p=0.003**    ] p=0.002**   
100 97.2±1.3 
 
p=0.009** 3.3 90.8±6.1  9.2 p=0.057  
S
t
r
i
a
t
u
m 
0 1.4±1.2  p=0.052 1.3 1.9±2.5  3.0 p=0.203 
  ] p=0.005**    ] p=0.018*   
25 18.0±8.1  p=0.125 10.0 7.9±2.9  14.7 p=0.002** 
  ] p=0.001***    ] p=0.003**   
50 43.9±5.8  p=0.211 6.2 21.0±4.1  18.1 p=0.005** 
  ] p=0.170    ] p=0.182   
75 55.7±16.5  p=0.179 19.3 28.1±13.2 
 31.6 p=0.006** 
  ] p=0.007** p=0.036*   ] p=0.005**   
100 96.9±2.2   3.2 96.5±4.6  3.7 p=0.095 
2Mean absolute deviation. 1Calculated with mean attenuation factor calculated from auto unmixing 244 
experiments: cortex x5r/x5g (5.99±2.46/10.99±6.85), striatum x5r/x5g (9.04±4.02/11.50±7.51). Statistical 245 
significance reported as p-value result of the t-test between a pair adjacent x5g ratios. 246 
Discriminating two different neural stem cell populations 247 
In order to further probe the spectral unmixing approach, we tested x5g in combination 248 
with the widely used Fluc Luc2 in neural stem cells (NSCs). The human H9-NSC line 249 
was stably transduced using EF1α-Luc2-T2A-copGFP or DCX-x5g-T2A-EGFP lentiviral 250 
vectors and sorted by FACS for their GFP expression, respectively (data not shown). 251 
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The resulting two stable transgenic cell lines were transplanted into the cortex of nude 252 
mice in the same mixture ratios as for the HEK 293T experiment (0/100, 25/75, 50/50, 253 
and 100/0% x5g/r) and imaged one and two days later [Fig. 6(a)]. The quantitative 254 
analysis revealed a linear correlation for both time points with a stronger correlation on 255 
the first day after transplantation [Fig. 6(b)]. The presence of the different cell types was 256 
verified by immunohistochemistry [Fig. 6(c)].  257 
Discussion 258 
We have recently characterized mutated luciferases originating from various species 259 
such as Photinus pyralis Fluc (Luc2, PpyRE9), Pyrophorus plagiopthalamus (CBG99), 260 
Gaussia princeps (Gluc), and Renilla reniformis (hRluc) for neuroimaging, which is 261 
particularly challenging, as the bioluminescent photons need to pass thick layers of 262 
bones and connective tissue. We further showed that spectral unmixing for CBG99 and 263 
PpyRE9 is possible also for deep tissue grafts, however, with limitation to qualitative 264 
analysis. 26 The aim of the present investigation was to optimize spectral unmixing for in 265 
vivo bioluminescent neuroimaging by using advanced green- and red-shifted Fluc 266 
mutants and characterize the accuracy to predict cell population ratios from quantitative 267 
unmixing results. 268 
The conventional in vitro dual-luciferase assay combines Renilla and firefly luciferases 269 
27
. These luciferases require different substrates (Fluc luciferin and Renilla 270 
coelenterazine), which makes the bioluminescent signal distinguishable. However, for 271 
many in vivo applications, the dual-luciferase approach is impractical because of the 272 
weak quantum yield, the absorption- and scattering-sensitive blue light emitted by 273 
Renilla, and it requires two separate imaging sessions. A different approach is spectral 274 
unmixing, a dissecting algorithm, which is able to partition bioluminescence signals 275 
originated from multiple fluorescence or luciferase sources into individual contributors 276 
16,28
. Although spectral unmixing is widely used in fluorescence microscopy for cell 277 
imaging 29, in vivo applications - especially for neuroimaging - are technically 278 
challenging. It requires sensitive BLI detectors and engineered luciferases with distinct in 279 
vivo spectra. In a previous study, which was the first to compare reporter genes 280 
specifically for mouse brain applications, we found the Fluc Luc2 to be superior to other 281 
luciferases and the quantum yield (amount of photons emitted per luciferin molecule 282 
processed) to be more important than emission wavelength 30. As we have shown here, 283 
tissue absorption and scattering have a significant impact on the luciferase spectrum, 284 
making the in vivo spectrum considerably different from that in vitro.  285 
For our comparison, we have used the previously described red-shifted x5 mutant18,19,31 286 
and a novel green-shifted complement, x5g. They are based on a background that has 287 
improved thermo-stability, solvent stability, pH-tolerance in terms of activity, and 288 
resistance to bathochromic shift while retaining the same specific activity relative to the 289 
wild type 18,23,31. As we could show here, x5g and x5r have superior quantum yields and 290 
a better spectral separation compared to the previously tested luciferases Luc2, 291 
PpyRE9, CBG99, and hRluc 30. The comparison of emission spectra from luciferases 292 
expressed by HEK 293T cells in vitro and in vivo highlights the strong overlap of the 293 
other green- and red-shifted luciferases with Luc2. The benefit of using x5g/x5r for 294 
spectral unmixing compared to CBG99/PpyRE9 is a much stronger separation due to 295 
higher photon flux and difference in spectrum shape. Especially under in vivo conditions, 296 
the less pronounced attenuation of the green shoulder of x5g compared to CBG99 297 
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favors spectral separation also from deep tissue sources. Furthermore, the green-shifted 298 
x5g is 1.79- and 3.69-fold brighter than CBG99 and Luc. Likewise, x5r is 2.24-fold 299 
brighter than PpyRE9 23,24 and the spectrum is characterized by a higher emission for 300 
wavelengths above 600 nm. Red-shifted probes are considered to be more efficient in 301 
vivo as light absorption in living tissue is negatively correlated with the emission 302 
wavelength 24,32,33. However, the lower quantum yield of red-shifted luciferases has so 303 
far impeded sensitive detection of cell grafts in deep tissues, like the mouse brain 26. 304 
The here tested x5r Fluc overcomes these limitations and was successfully validated for 305 
in vitro and in vivo spectral unmixing applications.  306 
Under in vitro conditions, the dual-luciferase pair x5r/g provided the best spectral 307 
separation for all measured wavelengths compared to previously tested red and green-308 
emitting luciferases 26. In this line, the unmixing of different ratios of transfected HEK 309 
cells was straightforward with a minimal mean absolute deviation (MAD) of 0.02±0.02. 310 
There was a highly significant linear correlation between cell number and (unmixed) 311 
photon emission. In order to get reliable results, a simple correction factor compensating 312 
for the individual filter attenuation must be applied. This filter attenuation is the relation 313 
between the luciferase photon emission without filter vs. with filter and commonly used 314 
for in vitro dual-color luciferase assays 34. We imaged a tissue-like phantom with Fluc-315 
expressing cells covered with a blood and fat composition of human skin to model the in 316 
vivo situation of transplanted cells in the living animal. Under these conditions, the 317 
attenuation of photon emission due to increasing amounts of blood/fat follows an 318 
exponential curve for both, x5g and x5r, while the difference in total photon emission 319 
remains constant (x5g higher than x5r). According to that experiment, we did not 320 
calculate an addition correction factor. However, the in vivo emission spectra from x5g- 321 
and x5r-expressing HEK cells transplanted into the mouse brain revealed a strong tissue 322 
depth-dependent difference compared to the in vitro cell culture and tissue model. Total 323 
photon counts for x5g were much lower than for x5r. The total x5r photon counts were 5-324 
fold and 1.8-fold higher compared to x5g cells in the cortex and striatum, respectively. 325 
The x5g peak emission was affected much stronger by tissue absorption compared to 326 
x5r, which is in agreement with other in vivo mouse brain studies using for example the 327 
red-shifted Fluc PRE9 32. Additional correction factors compensating for the Fluc-specific 328 
tissue absorption as determined for subcutaneous tumors in mice 35 would be an 329 
interesting target to further improve the quantification in future studies.   330 
We found that the spectral unmixing algorithm works best when 2 “control” mice with x5g 331 
and x5r engrafted cells were present to allow an automatic detection of “pure” light from 332 
each luciferase. Although, the emission spectra were strongly influenced by tissue 333 
absorption and scatter, statistical measures proved that for cortical grafts and with less 334 
precision for striatal grafts quantitative unmixing is feasible. The mean absolute 335 
deviation (MAD) for cells implanted in the cortex of adult mice was very low (4.5) and the 336 
correlation of unmixing and actual x5g values followed a strict linear correlation which is 337 
statistically not different, providing sufficient quantitative calculations of various mixtures 338 
in dual-color imaging in vivo. In absence of both control mice, however, the automatic 339 
unmixing algorithm tends to extract unrelated red and green components of the spectra 340 
which may lead to wrong calculations of x5r/g ratio. The sampling of master spectra and 341 
an average for the filter attenuation from a batch of independent experiments resolved 342 
this problem only partially. In detail, we found less efficient unmixing for both, cortical 343 
and striatal grafts under those conditions of using library data. While unmixing with the 344 
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generated library data (master spectra) predicts the ratio of x5g qualitatively good for 345 
cortical grafts, it underestimates x5g in the striatal grafts. We speculate that the stronger 346 
absorption of the green part of the spectrum negatively influences spectral unmixing 347 
efficiency. Nevertheless, when sampled from more experiments, the library mode could 348 
be useful for in vitro and ex vivo measurement, respectively, making controls and/or 349 
additional animals with the pure green- and red-shifted luciferases obsolete.   350 
Confounding factors for quantitative in vivo unmixing remain the biological variability in 351 
luciferin distribution, reporter gene expression and the stability of the image acquisition. 352 
Although the image acquisition was done in the steady-state of the luciferase activity (up 353 
to 30 min post luciferin injection 9), a random order of emission filters would prevent an 354 
effect of lower/higher values related to the time after substrate injection. In order to 355 
probe our spectral unmixing strategy in a more difficult application, we transduced 356 
human NSCs with x5g and Luc2 constructs and transplanted different ratios into the 357 
nude mouse brain. The dual-color luciferase pair x5g/Luc2 was chosen as quantum yield 358 
and spectral separation are very similar to x5g/r. Furthermore, in this proof-of-concept 359 
example, the widely used luciferase Luc2 is controlled by the constitutive human EF1α 360 
promoter, which maintains Luc2 levels independent of NSC maturation state 12. The x5g 361 
expression is driven by the DCX promoter and provides a second readout specific for 362 
early neurons. We could show that the dual-color luciferase approach is applicable to 363 
human NSCs and that spectral unmixing of in vivo BLI early after stem cell 364 
transplantation provides accurate and quantitative determination of undifferentiated vs. 365 
pre-differentiated cells. In our experiments, the estimation of x5g ratios in the mix was as 366 
good as for the HEK 293T cells at day 1 post implantation, but slightly worse the day 367 
after. This might be due to different cell death behavior of the two cell lines or varying 368 
DCX controlled reporter expression due to continuing neuronal differentiation. Due to 369 
technical limitations, we have used two GFP reporter, copGFP and EGFP, for both 370 
lentiviral vectors, which cannot be distinguished by fluorescence emission. In future 371 
experiments it will be necessary to mirror the red/green luciferase also with a set of 372 
equivalent fluorescent reporter to distinguish the cell types by histology. Notably, if a 373 
direct correlation of GFP to Fluc expression is needed, a measurement of the actual 374 
protein levels and the catalytic active protein, respectively, would be necessary 36. The 375 
T2A linker regulates bicistronic expression and not protein stability. Furthermore, 376 
spectral unmixing should be tested with other improved pairs of luciferases and luciferins 377 
such as AkaLumine-HCl8 with enhanced sensitivity for deep tissue imaging. With these 378 
technical improvements, imaging two different cell populations in the mouse brain at the 379 
same time has many important applications. In stem cell therapy of neurological 380 
disorders, for example, it could be used to monitor the viability and differentiation with 381 
two different colored luciferases in order to answer the question if the stem cell graft 382 
itself or an interplay of paracrine and immune-modulatory effects determine functional 383 
improvement. 384 
Conclusion 385 
Here, we have shown that spectral unmixing of dual-color bioluminescence reporter can 386 
determine the ratio of each luciferase. The unmixing was validated in human tumor and 387 
neural stem cells engrafted into the mouse brain cortex. Monitoring the expression of the 388 
two reporter genes by dual-color bioluminescence imaging holds great potential to 389 
advance luciferase-based in vitro and in vivo assays. It enables simultaneous imaging of 390 
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protein and cell interaction in health vs. disease condition and holds the potential to 391 
advance stem cell fate imaging.  392 
  393 
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Material&Methods 394 
Mutagenesis 395 
Thermostable x5 Fluc contains 5 mutations (F14R, L35Q, V182K, I232K, F465R) that 396 
reduce surface hydrophobicity and confer significant thermostability22. The sequence of 397 
human codon optimised WT Fluc was constructed by gene synthesis by oligo assembly 398 
and the 5 mutations were added by splicing by overlap extension PCR-based cloning to 399 
produce the plasmid MP5556x5, cloned into SFG-retrovirus37 upstream an internal 400 
ribosome entry site (IRES) and a truncated CD34 (dCD34) marker gene. Into this, 401 
mutations were added to either produce blue-shifted (V241I/G246A/F250S) and red-402 
shifted (S284T) bioluminescence spectra in mutants x5green (x5g) and x5red (x5r), 403 
respectively.  404 
Cell culture 405 
The human embryonic kidney cell line 293T (HEK 293T) was cultured in 406 
DMEM+GlutaMAX medium (Life Technologies, Darmstadt, Germany) supplemented with 407 
10% FBS (Life Technologies) and 1% Penicillin/Streptomycin (Life Technologies) under 408 
humidified conditions at 37 °C and 5% CO2. Cells were passaged every 3 days and 409 
detached with Trypsin (Life Technologies). The human neural stem cell line H9-NSC 410 
(Life Technologies), which were initially derived from the human embryonic stem cell line 411 
H9 - NIH Registry WA09 38 were maintained according to the manufacturer´s protocol. 412 
Briefly, cells were plated on Geltrex coating at a density of 5x104 cells/cm2 in StemPro 413 
NSC SFM complete medium consisting of 1x KnockOut DMEM/F-12, 2 mM GlutaMax, 414 
20 ng/mL bFGF and EGF, and 2% StemPro supplement (Life Technologies). Cells were 415 
passaged every 3 days and detached with StemPro Accutase (Life Technologies).  416 
Tissue-like phantoms 417 
Tissue-like phantom was prepared as follows: 8.76 mg/mL hemoglobin (Sigma-Aldrich) 418 
and 40 mg/mL blood agar base (Sigma-Aldrich) were solved in 50 mM TBS buffer on a 419 
hotplate stirrer at 50 °C. When both components were dissolved, Lipovenös MCT 420 
(Fresenius Kabi, Bad Homburg, Germany) was added at a final concentration of 1%. For 421 
the construction of the tissue phantom, the 96-well plate with the attached transfected 422 
cells was placed on a 37 °C warming pad, the medium was removed, and the agar 423 
mixture was layered carefully above the cells in various volumes ranging from 0 to 175 424 
µL.  425 
Cell transfection and transduction 426 
HEK 293T cells were transfected with the plasmids pcDH-EF1α-x5g-T2A-427 
tdtomato+SV40Zeo or pcDH-EF1α-x5r-T2A-copGFP+SV40Zeo which consist of the 428 
constitutive promoter elongation factor 1 alpha (EF1α), the genetically engineered x5 429 
Fluc red (+S284T) 18,19,31 and the novel green (+ V241I/G246A/F250S) mutant, the self-430 
cleaving 2A-like peptide sequence from Thosea asigna virus (T2A), the green 431 
fluorescent protein copGFP from Pontellina plumata (Exc 482nm, Em 502nm) or the red 432 
fluorescent protein tdTomato (Exc 554nm, Em 581nm), the Simian virus 40 (SV40) 433 
origin, and a Zeocin resistance gene (Zeo). Molecular cloning of plasmids carrying Luc2, 434 
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CBG99, PpyRE9, and hRluc was described previously 26. For this study, we designed 435 
novel bicistronic plasmids for constitutive and cell-specific expression of x5g and x5r by 436 
amplifying recombinant DNA by PCR using specific primers bearing appropriate 437 
restriction sites in the following steps. At first the backbone pcDH-EF1α-MCS-T2A-438 
copGFP (System Biosciences, Mountain View, USA) was changed to pCDH-EF1α-439 
MCS-T2A-tdTomato (pQC NLS TdTomato IX was a gift from Connie Cepko; Addgene 440 
plasmid #37347). In addition, we added the antibiotic resistance gene zeocin controlled 441 
by the independent SV40 promoter amplified from pBabe Zeo (pBABE zeo Ecotropic 442 
Receptor was a gift from William Hahn, Addgene plasmid #10687). Secondly, x5g or x5r 443 
were cloned with BamHI/NotI from M5556X5 or M5549X5 into pcDH-EF1α-MCS-T2A-444 
tdtomato+SV40Zeo or pcDH-EF1α-MCS-T2A-copGFP+SV40Zeo. For the cell specific 445 
plasmids, fluorescence proteins were exchanged to tdTomato and EGFP (pmEGFP-1 446 
was a gift from Benjamin Glick, Addgene plasmid #36409). The EF1α promoter was 447 
exchanged by the human DCX promoter (kind gift of Sebastien Couillard-Despres, 448 
Paracelsus Medical University, Salzburg, Austria) via ligation with the ClaI and XbaI 449 
restriction sites. The final plasmids used for transduction of H9-NSCs were: pcDH-EF1α-450 
Luc2-T2A-copGFP and pcDH-DCX-x5green-T2A-EGFP. Successful cloning was verified 451 
by restriction analysis and sequencing. 452 
For transient transfection, HEK 293T cells were seeded (71,400 cells/cm2) on gelatine 453 
coated P60 cell culture dishes 12 h before transfection. Cells were transfected with 5.25 454 
µg DNA and 10.5 µL Metafectene (Biontex, Munich, Germany) in 2 mL Opti-MEM 455 
medium (Life Technologies) and incubated for 4 h under normal conditions. Post 456 
transfection, cells were cultured for 2 to 3 days and prepared for in vitro dilution series or 457 
in vivo implantation.  458 
Lentiviral vector-mediated transduction of H9-NSCs was performed using 3rd generation 459 
helper plasmids and subsequent cell incubation with unconcentrated pseudoviral 460 
particles for 24 h (for experimental details see 12). We selected stably expressing cell 461 
lines based on the LTR-mediated background expression of EGFP and copGFP in the 462 
transduced cells via FACS (FACSAria III, BD Biosciences, San Jos, USA).    463 
Cell Transplantation 464 
All experiments were conducted according to the guidelines laid out in the German 465 
Animal Welfare Act and approved by the local authorities. Animals were kept in 12 h/12 466 
h day/night cycle in individually ventilated cages. Food and water were offered ad 467 
libitum. 468 
Cells transplantation was performed as described before 9. Transfected HEK 293T cells 469 
were implanted individually or mixed (x5r:x5g; 1:1, 1:3 and 4:1) diluted with a final 470 
concentration of 150,000 cells/µL in HBSS (Life Technologies) and stored on ice until 471 
implantation. Cells were implanted into the right striatum (AP +0.5; L +2.0; DV −3.0 472 
relative to bregma) or cortex (AP +0.5; L +2.0; DV −1.5 relative to bregma) of NMRI-473 
Foxn1nu/Foxn1nu mice (age 9-11 weeks, 25–30 g, male from Janvier, Saint Berthevin 474 
Cedex, France). In total, we used 28 mice for cortical and 26 for striatal HEK 293T grafts 475 
of which 6 and 3, respectively, were excluded because of visual bleeding out of the bore 476 
hole.   477 
In vitro and in vivo imaging set-up 478 
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Bioluminescence and fluorescence imaging experiments were performed with the IVIS 479 
Spectrum CT (PerkinElmer, Waltham, USA). We recorded emission spectra explicitly 480 
with the IVIS system as we used the system throughout all experiments and it was 481 
shown by Zhao and colleagues previously that recording emission spectra with the IVIS 482 
System results in comparable spectra acquired with a spectrophotometer 24.  483 
For spectral unmixing of the in vitro dilution series respective cell numbers were diluted 484 
in PBS (Life Technologies) and plated on a black clear bottom 96-well plate (Sigma-485 
Aldrich, Taufkirchen, Germany). D-luciferin potassium salt (Synchem, Felsberg, 486 
Germany) was solved in PBS and added in a final concentration of 1 mM (~0.3 mg/mL). 487 
Immediately after D-luciferin application, in vitro dilution series was imaged with 488 
following settings: FOV 13.2 cm, Excitation Block, Emission 500 to 840 nm (20 nm 489 
bandpass filter) and no filter (open filter setting), exposure time automatic, binning 8, 490 
f/stop 1. In addition, copGFP fluorescence was measured using the plate reader 491 
Mithras2 LB943 (Berthold, Bad Wildbach, Germany) with the following settings: 492 
Excitation 469 nm, Emission 510 nm, lamp energy 40%, counting time 2.0 sec. In vivo 493 
BLI was performed one day post implantation. We used our mouse brain-adapted 494 
imaging protocol, which was described in detail elsewhere 9. 50 mg/mL D-luciferin 495 
sodium salt (Synchem) was solved in PBS, sterile filtered, and injected intraperitoneally 496 
to each animal with a final dose of 300 mg/kg body weight before Isoflurane (ISO) 497 
anesthesia (2% ISO in 30% O2/70% N2O atmosphere). Image acquisition was started 8 498 
min post D-luciferin injection for 25 min under following setting: FOV 22.5 cm, Excitation 499 
Block, Emission 500 to 840 nm with 20 nm bandwidth and open filter. The exposure time 500 
ranging from 1 to 60 sec, the lens aperture size, and the binning were set automatically 501 
by the system to reach the most sensitive setting. Finally, animals were sacrificed and 502 
brain tissues were processed for histology. 503 
Immunostainings 504 
For immunohistological staining of brain tissues, mice were transcardially perfused 505 
under ISO anesthesia with 20 mL PBS followed by 20 mL 4% phosphate buffered 506 
paraformaldehyde (PFA). Brains were removed and frozen in -40 °C cold 2-507 
methylbutane and stored at -80 °C. Brains were cut in 14 µm thick sections in coronal 508 
plane with the cryostat (Leica, Wetzlar, Germany), mounted on object slides, and stored 509 
at -20 °C. To equilibrate tissue, brain sections were washed 3 times with PBS. Antigen 510 
retrieval was performed by incubating the brain sections in 10 mM sodium citrate buffer 511 
(pH 6.0) at 80 °C for 30 min. Unspecific antibody binding was reduced by blocking with 512 
5% normal donkey serum and 0.25% Triton X-100 in PBS for 1 h. Primary antibodies 513 
were diluted with 0.25% Triton X-100 in PBS and incubated overnight at 4 °C. Brain 514 
sections were stained for mouse anti-HuNu (Chemicon, 1:200) and rabbit anti-copGFP 515 
(Evrogen, 1:200). Secondary antibodies – donkey anti-mouse-Cy5 (Jackson 516 
Immunoresearch, 1:200) and donkey anti-rabbit-Cy3 (Jackson Immunoresearch, 1:200) 517 
– were diluted with 0.25% Triton X-100 and Hoechst 33342 (Sigma-Aldrich, 1:000) in 518 
PBS and incubated for 2 h. Finally, brain sections were air-dried and mounted within 519 
Cytoseal XYL (Thermo Fisher Scientific). 520 
All images were acquired with the BZ-9200 Microscope (Keyence, Neu-Isenburg, 521 
Germany). Representative images of the immunohistological staining were acquired with 522 
the 4x and 60x objectives and the respective phase contrast and fluorescence filter sets 523 
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(DAPI-BP, GFP-BP, TexRed, and Cy5 HC; Keyence). 524 
Data analysis 525 
Optical imaging data analysis and spectral unmixing was performed with the Living 526 
Image 4.3.1 software (PerkinElmer). Regions of interest (ROIs) with constant size were 527 
manually drawn for well plate quantification as well as in vivo data. Total photon flux was 528 
calculated as area under curve as described previously 9 and the filter with highest 529 
average radiance was selected as emission with maximum photon flux. The normalized 530 
as well as non-normalized master spectrum for x5g and x5r in the striatum or cortex 531 
were calculated by the average of 4 or 3 different acquisitions. The master spectrum 532 
was used in the “library” mode for spectral unmixing as guideline. The automatic (“auto”) 533 
spectral algorithm was used whenever possible, or replaced by the (manual) guided 534 
unmixing in which the user has to pre-define where to find the pure x5g and x5r spectra. 535 
The data for the unmixed populations of x5g and x5r were corrected for the experiment-536 
specific filter attenuation factor. This factor compensates for the difference between the 537 
average radiance of x5g/r unmixing at a certain filter (usual 600-620/620-640 nm) and 538 
the open filter (without filter) setting. Furthermore, this correction factor grades the 539 
experimental variability induced by the differences during transfection and 540 
transplantation. Without correcting for filter attenuation, the unmixing results will remain 541 
qualitative. The filter attenuation factor average of all processed cortical and striatal 542 
grafts was used for the master spectrum unmixing.  543 
Histological images were processed with ImageJ 1.48s (National Institutes of Health, 544 
Bethesda, USA). Further calculations, plotting, and statistical analysis were done with 545 
MS-Excel 2010 (Microsoft Corporation, Redmond, USA) and SPSS 22.0 (IBM, 546 
Ehningen, Germany). For multiple group comparisons the one-way ANOVA with Welch 547 
statistics and post hoc pairwise comparison (Tukey-corrected) was used. A p-value ≤ 548 
0.05 was considered to be significant. A Student’s t-test was used for the comparison of 549 
experimental groups. The one sample t-test was used to compare unmixing results with 550 
the implanted x5g ratio. The mean absolute deviation (MAD) is the difference between 551 
actual values and the known values (implanted x5g cells). All values are expressed as 552 
mean ± standard deviation (SD) and statistical significance are indicated by *p<0.05, 553 
**p<0.01, ***p<0.001., # n.s. 554 
 555 
 556 
 557 
 558 
 559 
 560 
 561 
 562 
 563 
 564 
 565 
 566 
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 706 
Figure legends 707 
 708 
Fig. 1: Comparison of Luc2, CBG99, PpyRE9, x5g, x5r, and hRluc emission specra 709 
in vitro. Plotted is the photon emission from EF1α-luciferase-T2A-copGFP transfected 710 
HEK 293T cells recorded with the IVIS Spectrum CT system (mean of n=4-6). Photon 711 
emission was normalized to the individual copGFP expression. Graph with grey 712 
background is a zoom-in for 580-700 nm to highlight differences in the red part of the 713 
spectra.  714 
 715 
Fig. 2. Unmixing of x5g and x5r luciferases expressed by HEK 293T cells. (a) 716 
Fluorescence microscopy overlay with phase contrast image of cells at 2 days post 717 
transfection, used for the unmixing experiment (scale bar 25 µm). (b) Unmixed spectra 718 
of x5r and x5g calculated by the unmixing algorithm. (c) Plating scheme for x5g and x5r 719 
cells in different numbers (n=3) and the corresponding false-colored unmixed result 720 
displayed as green/red composite as well as the open filter, x5g, and x5 red unmixed 721 
images. (d) Plot of measured unmixed x5g and x5r photon flux plotted vs. the plated 722 
ratio of x5g cells in the mix (n=3). Linear fitting for both luciferases underlines high 723 
accuracy of unmixed values with plated cells.   724 
 725 
Fig. 3: In vitro modeling of superficial vs. deep x5g and x5r Fluc sources with 726 
tissue-like agarose. (a) Different volumes of tissue-like agarose were placed above the 727 
HEK 293T cell layer to mimic overlaying tissue in different thickness. Micrographs 728 
represent selected bioluminescence/photo overlays from the x5g and x5r unmixing, 729 
respectively. (b) Quantitative analysis and polynomial fit for the decreasing photon 730 
emission, detected when more blood agar volume was added.  731 
 732 
Fig. 4: In vivo emission spectra of x5g and x5r in comparison to Luc2, CBG99, PpyRE9, 733 
and hRluc expressed in mammalian cells implanted in the mouse brain (data in part 734 
adapted from our previous publication comparing different luciferases 26). 735 
 736 
Fig. 5. Spectral unmixing efficiently determines x5g/r cell ratios in vivo. Transiently 737 
transfected HEK 293T cells expressing x5g or x5r luciferases were transplanted into the 738 
cortex (a) or striatum (d) and bioluminescence imaging was applied 1 day later. Non-739 
normalized spectra from the x5g and x5r cells differ, dependent on transplantation 740 
depth: cortex (b), striatum (e). Spectral unmixing of x5g ratio is in good agreement with 741 
expected (dotted line) x5g ratio for the cortical (c) as well as striatal (f) grafts. Significant 742 
differences are highlighted by asterisks. 743 
 744 
Fig. 6. Spectral unmixing of two neural stem cell (NSC) populations. (a) NSC lines 745 
expressing x5g or Luc2 were implanted in different ratios into the cortex of nude mice. 746 
(b) Quantitative analysis of spectral unmixing from imaging data acquired 1 day and 2 747 
days post implantation (dpi). (c) Representative immunohistochemical staining of an 748 
NSC graft (EF1α-Luc2-T2A-copGFP). Human nuclei (HuNu) to discriminate the human 749 
cell graft in the mouse brain. Enhanced copGFP with anti-copGFP antibody to visualize 750 
transplanted cells expressing the transgene. Hoechst to visualize cell nuclei. Scale bar 751 
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